SI9012150A - Oralni pripravek za zdravljenje vnetnih črevesnih bolezni - Google Patents

Oralni pripravek za zdravljenje vnetnih črevesnih bolezni Download PDF

Info

Publication number
SI9012150A
SI9012150A SI9012150A SI9012150A SI9012150A SI 9012150 A SI9012150 A SI 9012150A SI 9012150 A SI9012150 A SI 9012150A SI 9012150 A SI9012150 A SI 9012150A SI 9012150 A SI9012150 A SI 9012150A
Authority
SI
Slovenia
Prior art keywords
epimer
butylidenedioxy
glucocorticosteroid
dione
diene
Prior art date
Application number
SI9012150A
Other languages
English (en)
Slovenian (sl)
Inventor
Jan Ulmius
Original Assignee
Aktiebolaget Draco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9012150(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aktiebolaget Draco filed Critical Aktiebolaget Draco
Publication of SI9012150A publication Critical patent/SI9012150A/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
SI9012150A 1989-11-22 1990-11-13 Oralni pripravek za zdravljenje vnetnih črevesnih bolezni SI9012150A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases
YU215090A YU48583B (sh) 1989-11-22 1990-11-13 Postupak za pripremanje formulacije u obliku pilule za oralno davanje

Publications (1)

Publication Number Publication Date
SI9012150A true SI9012150A (sl) 1998-08-31

Family

ID=20377544

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9012150A SI9012150A (sl) 1989-11-22 1990-11-13 Oralni pripravek za zdravljenje vnetnih črevesnih bolezni

Country Status (36)

Country Link
US (1) US6423340B1 (ko)
EP (1) EP0502092B1 (ko)
JP (1) JP3145111B2 (ko)
KR (1) KR0179042B1 (ko)
AT (1) ATE125445T1 (ko)
AU (1) AU643021B2 (ko)
CA (1) CA2071518C (ko)
DE (1) DE69021214T2 (ko)
DK (1) DK0502092T3 (ko)
EG (1) EG19642A (ko)
ES (1) ES2074698T3 (ko)
FI (2) FI104949B (ko)
GR (1) GR3017691T3 (ko)
HK (1) HK51897A (ko)
HR (1) HRP920632B1 (ko)
HU (2) HU216836B (ko)
IE (1) IE74854B1 (ko)
IL (1) IL96415A (ko)
IS (1) IS1858B (ko)
LT (1) LT3696B (ko)
LV (1) LV10183B (ko)
MY (1) MY104535A (ko)
NO (1) NO304010B1 (ko)
NZ (1) NZ235807A (ko)
PL (1) PL166506B1 (ko)
PT (1) PT95946A (ko)
RU (1) RU2134104C1 (ko)
SA (1) SA90110123B1 (ko)
SE (1) SE8903914D0 (ko)
SG (1) SG54210A1 (ko)
SI (1) SI9012150A (ko)
TW (1) TW250435B (ko)
UA (1) UA37196C2 (ko)
WO (1) WO1991007172A1 (ko)
YU (1) YU48583B (ko)
ZA (1) ZA908777B (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
JP3366640B2 (ja) * 1993-01-08 2003-01-14 アストラ・アクチエボラーグ 新規な結腸−または回腸−特異的ステロイド誘導体
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
AU739031B2 (en) * 1996-11-15 2001-10-04 Procter & Gamble Company, The Pharmaceutical dosage form for colonic delivery
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
DE60237363D1 (de) * 2001-03-15 2010-09-30 Soligenix Inc Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
US20060188563A1 (en) * 2003-03-27 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
US20060211668A1 (en) * 2003-09-15 2006-09-21 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
US20070243184A1 (en) * 2005-11-08 2007-10-18 Steven Fischkoff Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
WO2008117814A1 (ja) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. 大腸送達用経口製剤
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
EP2334178A4 (en) * 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945616B2 (en) 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
WO2012106722A2 (en) * 2011-02-04 2012-08-09 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
MD480Z (en) * 2011-07-07 2012-09-30 Elvira Andon Method for treating acute ulcerative nonspecific colitis
LT2659881T (lt) 2012-04-30 2018-02-12 Tillotts Pharma Ag Uždelsto atpalaidavimo vaisto forma
EP3542791A1 (en) 2013-10-29 2019-09-25 Tillotts Pharma AG A delayed release drug formulation
EP3346996A4 (en) * 2015-09-11 2019-04-17 Sun Pharmaceutical Industries Limited ORAL PHARMACEUTICAL PHARMACEUTICAL FORM OF BUDESONID
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
RU2750944C2 (ru) * 2016-02-09 2021-07-06 Альбирео Аб Пероральный состав холестирамина и его применение
EP3413878B1 (en) * 2016-02-09 2021-04-14 Albireo AB Oral cholestyramine formulation and use thereof
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (ko) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
HUT60630A (en) 1992-10-28
NO304010B1 (no) 1998-10-12
EG19642A (en) 1995-08-30
YU48583B (sh) 1998-12-23
IS3644A7 (is) 1991-05-23
HK51897A (en) 1997-05-02
AU643021B2 (en) 1993-11-04
IL96415A (en) 1995-11-27
NO922004D0 (no) 1992-05-21
PL166506B1 (pl) 1995-05-31
KR0179042B1 (ko) 1999-03-20
CA2071518A1 (en) 1991-05-23
NZ235807A (en) 1993-02-25
WO1991007172A1 (en) 1991-05-30
ES2074698T3 (es) 1995-09-16
FI922325A0 (fi) 1992-05-21
NO922004L (no) 1992-05-21
HRP920632A2 (en) 1995-04-30
KR920703025A (ko) 1992-12-17
FI922325A (fi) 1992-05-21
IL96415A0 (en) 1991-08-16
SG54210A1 (en) 1998-11-16
EP0502092A1 (en) 1992-09-09
ATE125445T1 (de) 1995-08-15
SA90110123B1 (ar) 1999-06-06
JP3145111B2 (ja) 2001-03-12
DE69021214D1 (de) 1995-08-31
PL287844A1 (en) 1991-12-02
GR3017691T3 (en) 1996-01-31
JPH05501705A (ja) 1993-04-02
PT95946A (pt) 1991-09-13
YU215090A (sr) 1996-01-09
RU2134104C1 (ru) 1999-08-10
FI19991893A (fi) 1999-09-06
LTIP1751A (en) 1995-07-25
DK0502092T3 (da) 1995-12-27
CA2071518C (en) 2002-11-12
EP0502092B1 (en) 1995-07-26
HU216836B (hu) 1999-09-28
IS1858B (is) 2003-03-27
US6423340B1 (en) 2002-07-23
IE904170A1 (en) 1991-05-22
FI104949B (fi) 2000-05-15
HRP920632B1 (en) 1999-10-31
LV10183A (lv) 1994-10-20
SE8903914D0 (sv) 1989-11-22
TW250435B (ko) 1995-07-01
AU7786491A (en) 1991-06-13
MY104535A (en) 1994-04-30
IE74854B1 (en) 1997-08-13
LV10183B (en) 1995-08-20
ZA908777B (en) 1991-07-31
DE69021214T2 (de) 1996-01-04
LT3696B (en) 1996-02-26
UA37196C2 (uk) 2001-05-15
HU9201700D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
SI9012150A (sl) Oralni pripravek za zdravljenje vnetnih črevesnih bolezni
US5643602A (en) Oral composition for the treatment of inflammatory bowel disease
CA1302262C (en) Pharmaceutical composition containing flutiasone propionate
CA2170748C (en) Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US20060057200A1 (en) Tablets with site- and time-controlled gastrointestinal release of active ingredient
CZ281792B6 (cs) Orálně podávatelná farmaceutická dávkovací forma pro selektivní podávání léčiva do střev
ITMI20001603A1 (it) Formulazioni farmaceutiche solide orali a rilascio multifasico ph-dipendente
JPH04224517A (ja) 標的制御釈放薬剤
CZ204995A3 (en) Pharmaceutical preparation and method of its use for achieving laxative effect
CA2579732C (en) Tablets with site time-controlled gastrointestinal release of active ingredient
JP2967492B2 (ja) 腸内適所放出経口製剤
EP1315481A1 (de) Arzneimittel zur behandlung von darmerkrankungen
KR20000053326A (ko) 결장내 운반에 사용되는 다층 장용성 중합체 코팅물을 갖는 약제학적 제형
EP1100481B1 (en) Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
JP5371189B2 (ja) 炎症性腸疾患の治療のためのシクレソニドの使用
Loefberg 20 How to use steroids in inflammatory bowel disease
WO1994007503A1 (en) Enteric preparations
JPS62111919A (ja) プロプラノロ−ル製剤

Legal Events

Date Code Title Description
IF Valid on the event date